Frontiers in Immunology (Jun 2022)

Corrigendum: Pan-Cancer Analysis Shows That ALKBH5 Is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Gliomas

  • Cheng Wei,
  • Bo Wang,
  • Dazhao Peng,
  • Xiaoyang Zhang,
  • Zesheng Li,
  • Lin Luo,
  • Yingjie He,
  • Hao Liang,
  • Xuezhi Du,
  • Shenghui Li,
  • Shu Zhang,
  • Zhenyu Zhang,
  • Lei Han,
  • Jianning Zhang

DOI
https://doi.org/10.3389/fimmu.2022.944740
Journal volume & issue
Vol. 13

Abstract

Read online

No abstracts available.

Keywords